These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27021628)

  • 1. A mesoporous nanocontainer gated by a stimuli-responsive peptide for selective triggering of intracellular drug release.
    Lee J; Oh ET; Yoon H; Kim H; Park HJ; Kim C
    Nanoscale; 2016 Apr; 8(15):8070-7. PubMed ID: 27021628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous Silica Nanocarriers with Cyclic Peptide Gatekeeper: Specific Targeting of Aminopeptidase N and Triggered Drug Release by Stimuli-Responsive Conformational Transformation.
    Lee J; Oh ET; Han Y; Kim HG; Park HJ; Kim C
    Chemistry; 2017 Dec; 23(67):16966-16971. PubMed ID: 29077239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells.
    Lee H; Kim S; Choi BH; Park MT; Lee J; Jeong SY; Choi EK; Lim BU; Kim C; Park HJ
    Int J Hyperthermia; 2011; 27(7):698-707. PubMed ID: 21992562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus-Induced Conformational Transformation of a Cyclic Peptide for Selective Cell-Targeting On-Off Gatekeeper for Mesoporous Nanocarriers.
    Lee J; Oh ET; Song J; Kim HG; Park HJ; Kim C
    Chem Asian J; 2017 Nov; 12(21):2813-2818. PubMed ID: 28921899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
    Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
    Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive conformational conversion of peptide gatekeepers for controlled release of guests from mesoporous silica nanocontainers.
    Lee J; Kim H; Han S; Hong E; Lee KH; Kim C
    J Am Chem Soc; 2014 Sep; 136(37):12880-3. PubMed ID: 25188823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
    Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.
    Xiao D; Jia HZ; Ma N; Zhuo RX; Zhang XZ
    Nanoscale; 2015 Jun; 7(22):10071-7. PubMed ID: 25978679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive biodegradable PEGylated nanographene oxide for efficiently chemo-photothermal therapy: a comparative study with non-biodegradable PEGylated nanographene oxide.
    Xiong H; Guo Z; Zhang W; Zhong H; Liu S; Ji Y
    J Photochem Photobiol B; 2014 Sep; 138():191-201. PubMed ID: 24976623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
    Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S
    ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
    Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
    Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
    Du X; Xiong L; Dai S; Qiao SZ
    Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
    Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
    Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.